Imperial College London

Dr Antonio J Berlanga-Taylor

Faculty of MedicineSchool of Public Health

Honorary Senior Research Fellow
 
 
 
//

Contact

 

a.berlanga

 
 
//

Location

 

47 Praed StreetSt Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Berlanga-Taylor:2018:10.1007/978-1-4939-7868-7_15,
author = {Berlanga-Taylor, AJ},
doi = {10.1007/978-1-4939-7868-7_15},
journal = {Methods Mol Biol},
pages = {259--275},
title = {From Identification to Function: Current Strategies to Prioritise and Follow-Up GWAS Results.},
url = {http://dx.doi.org/10.1007/978-1-4939-7868-7_15},
volume = {1793},
year = {2018}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - Along with family-based studies, dozens of genome-wide association studies (GWAS) have clearly identified the genetic basis of common diseases and complex traits. There are currently hundreds of single nucleotide polymorphisms (SNP) associated with human disease as well as biochemical and physiological phenotypes. Although this is only the tip of the iceberg, we are now confronted with a general lack of understanding of how these trait-associated variants act. How do these genetic changes lead to overt clinical phenotypes? What are the molecular mechanisms? Can we harness this information to develop better preventive and curative strategies? Current efforts are shifting to focus on these questions as we move from identifying variants to understanding their effects. Here I provide a broad overview of the main technical concerns and current bottlenecks as we approach this new phase.
AU - Berlanga-Taylor,AJ
DO - 10.1007/978-1-4939-7868-7_15
EP - 275
PY - 2018///
SP - 259
TI - From Identification to Function: Current Strategies to Prioritise and Follow-Up GWAS Results.
T2 - Methods Mol Biol
UR - http://dx.doi.org/10.1007/978-1-4939-7868-7_15
UR - https://www.ncbi.nlm.nih.gov/pubmed/29876901
VL - 1793
ER -